PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
68.51%
Revenue growth above 1.5x NEM's 27.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
62.95%
Gross profit growth 1.25-1.5x NEM's 43.74%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
82.56%
EBIT growth similar to NEM's 87.95%. Walter Schloss might infer both firms share similar operational efficiencies.
82.56%
Operating income growth similar to NEM's 87.95%. Walter Schloss would assume both share comparable operational structures.
82.05%
Net income growth above 1.5x NEM's 26.80%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
57.14%
EPS growth above 1.5x NEM's 27.42%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
83.33%
Diluted EPS growth above 1.5x NEM's 27.42%. David Dodd would see if there's a robust moat protecting these shareholder gains.
5.19%
Share change of 5.19% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
5.38%
Diluted share change of 5.38% while NEM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
71.55%
OCF growth at 50-75% of NEM's 108.09%. Martin Whitman would question if the firm lags in monetizing sales effectively.
-769.02%
Negative FCF growth while NEM is at 991.78%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
201.56%
10Y revenue/share CAGR above 1.5x NEM's 116.18%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
No Data
No Data available this quarter, please select a different quarter.
17.40%
3Y revenue/share CAGR under 50% of NEM's 70.76%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.53%
Below 50% of NEM's 135.42%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
12.86%
3Y OCF/share CAGR under 50% of NEM's 330.61%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
261.32%
5Y net income/share CAGR above 1.5x NEM's 171.93%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
4.77%
Below 50% of NEM's 79.96%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
1398.92%
10Y equity/share CAGR above 1.5x NEM's 143.64%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-82.05%
Negative 5Y equity/share growth while NEM is at 17.08%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
87.66%
3Y equity/share CAGR above 1.5x NEM's 0.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
71.67%
Our AR growth while NEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
57.25%
Asset growth above 1.5x NEM's 16.76%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
19.91%
BV/share growth above 1.5x NEM's 8.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
88.69%
Debt growth far above NEM's 62.42%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-11.89%
We cut SG&A while NEM invests at 17.50%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.